BioStem Technologies, Inc. Announces Letter of Intent with CCM Pharma Solutions to Co-Develop Multiple Solid to Liquid Dose Drugs Through 505(b)(2) Accelerated FDA Approval Process
26 mars 2018 19h22 HE
|
BioStem Technologies, Inc.
Pompano Beach, FL, March 26, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM) (“BioStem” or the “Company”), a global life sciences corporation providing innovative technologies with a...
BioStem Technologies Inc. Announces Engagement of Dr. Felix Amon for Pharmaceutical Business Development
13 mars 2018 18h16 HE
|
BioStem Technologies, Inc.
Pompano Beach, FL, March 13, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies with...
BioStem Technologies Inc. Enter into Agreement with Barbara Krutchkoff, PhD. To Guide Scientific Affairs
09 mars 2018 17h09 HE
|
BioStem Technologies, Inc.
Pompano Beach, FL, March 09, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies with...
BioStem Technologies Inc. Announces Intent to Acquire GIINT
26 févr. 2018 20h27 HE
|
BioStem Technologies, Inc.
Pompano Beach, FL, Feb. 26, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies...
BioStem Technologies Inc. Applies for Uplisting to the OTCQX Market
16 févr. 2018 09h44 HE
|
BioStem Technologies, Inc.
Pompano Beach, FL, Feb. 16, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies...
BioStem Technologies Inc. Announces New Transfer Agent, V Stock Transfer
09 févr. 2018 10h39 HE
|
BioStem Technologies, Inc.
Pompano Beach, FL, Feb. 09, 2018 (GLOBE NEWSWIRE) -- Pompano Beach, FL (GLOBE NEWSWIRE) – BioStem Technologies, Inc. (OTC PINK: BSEM) (the “Company”) announced today that it has changed the transfer...
BioStem Technologies Adds Chief Revenue Officer to Executive Team
08 févr. 2018 17h00 HE
|
BioStem Technologies, Inc.
Pompano Beach, FL, Feb. 08, 2018 (GLOBE NEWSWIRE) -- (GLOBE NEWSWIRE) – BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing...
BioStem Technologies, Inc. Announces the Engagement of Investment Banking Firm Young America Capital for 15 Million Dollar 506(c) Offering.
26 janv. 2018 09h45 HE
|
BioStem Technologies, Inc.
Pompano Beach, FL, Jan. 26, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BSEM” or “Company”) announced today the engagement of investment banking firm Young America Capital...
BioStem Technologies Inc. Announces New Board Member, Dr. Jennie Sandqvist
24 janv. 2018 10h05 HE
|
BioStem Technologies, Inc.
Pompano Beach, FL, Jan. 24, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BSEM” or “Company”) announced today that Dr. Jennie Sandqvist has joined the Company’s Board of...
BioStem Technologies Inc. Announces a Pre-Clinical Study of BSEM17-115 at University of Miami
11 déc. 2017 09h43 HE
|
BioStem Technologies, Inc.
Pompano Beach, FL, Dec. 11, 2017 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BSEM” or “Company”), in collaboration with the University of Miami’s Department of Dermatology and...